Search Results - "Plested G"

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.

Authors: Cook JA Patten PEM Peckham N et al.

Source: The Lancet. Haematology [Lancet Haematol] 2025 Apr; Vol. 12 (4), pp. e294-e303.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Equivalence Trial

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE